Paul S. Herendeen
Overview
Paul S. Herendeen received an average of $10M in total compensation, including $842K in salary, at Valeant Pharmaceuticals International from 2016 to 2021. Paul Herendeen also received an average of $2M at Zoetis from 2014 to 2016.
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015
- 2014
Valeant Pharmaceuticals InternationalFormer Executive Vice President and Chief Financial Officer
Valeant Pharmaceuticals InternationalFormer Executive Vice President and Chief Financial Officer
Valeant Pharmaceuticals InternationalFormer Executive Vice President and Chief Financial Officer
Valeant Pharmaceuticals InternationalExecutive Vice President and Chief Financial Officer
Valeant Pharmaceuticals InternationalExecutive Vice President and Chief Financial Officer
Valeant Pharmaceuticals InternationalExecutive Vice President and Chief Financial Officer
ZoetisFormer Executive Vice President and Chief Financial Officer
ZoetisFormer Executive Vice President and Chief Financial Officer
ZoetisFormer Executive Vice President and Chief Financial Officer
Source: SEC filings on May 2, 2022, March 18, 2019, March 21, 2018, and March 31, 2017.
Related executives
We found 37 more executives who work or worked at Valeant Pharmaceuticals International and Zoetis.
Joseph Papa
Valeant Pharmaceuticals International
Chief Executive Officer
Kristin Peck
Zoetis
Chief Executive Officer
Thomas Appio
Valeant Pharmaceuticals International
President Co, Head Bausch + Lomb/International
Wetteny Joseph
Zoetis
Chief Financial Officer
Glenn David
Zoetis
Chief Financial Officer
Christina Ackermann
Valeant Pharmaceuticals International
General Counsel
Sam Eldessouky
Valeant Pharmaceuticals International
Chief Financial Officer
Robert Spurr
Valeant Pharmaceuticals International